Valuation: AroCell AB

Market Cap 97.21M 9.99M 8.75M 8.08M 7.54M 14.2M 945M 14.52M 37.53M 466M 37.53M 36.71M 1.62B P/E 2024
-2.12x
P/E 2025 -6.69x
Enterprise Value 73.87M 7.59M 6.65M 6.14M 5.73M 10.79M 718M 11.04M 28.52M 354M 28.52M 27.89M 1.23B EV / Sales 2024
0.73x
EV / Sales 2025 1.09x
Free-Float
58.63%
Yield 2024 *
-
Yield 2025 -
1 day-0.47%
1 week-1.41%
Current month-12.50%
1 month-9.48%
3 months+51.08%
6 months+18.98%
Current year+18.98%
1 week 0.38
Extreme 0.38
0.45
1 month 0.38
Extreme 0.38
0.51
Current year 0.25
Extreme 0.25
0.53
1 year 0.25
Extreme 0.25
0.58
3 years 0.25
Extreme 0.25
0.66
5 years 0.25
Extreme 0.25
6.7
10 years 0.25
Extreme 0.25
8.45
Manager TitleAgeSince
Chief Executive Officer - 2026-05-27
Director of Finance/CFO - 2022-08-17
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 56 2019-12-31
Chairman 39 2024-05-21
Director/Board Member 74 2022-12-31
Date Insider Type Main position Quantity % Market Cap.
21-09-01Buy

Executive/Senior Manager

25,000 0.0220%
21-09-01Buy 20,000 0.0176%
21-08-31Buy 15,000 0.0132%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%-1.41%-20.15%-23.64% 9.99M
+1.11%+5.67%-3.65%+2.06% 46.62B
-1.51%+12.17%+416.83%+610.80% 40.95B
-0.25%+12.79%+22.58%-14.05% 32.26B
-1.25%+3.45%+18.01%+60.22% 32.24B
+8.02%+6.35%+17.67%+34.73% 25.53B
+0.98%+11.49% - - 16.38B
-0.07%+13.42%+71.11%+123.61% 15.27B
-0.03%+4.48%+12.77%+17.19% 13.61B
-0.90%+5.50%+102.91%+95.39% 13.34B
Average +0.53%+10.52%+70.90%+100.70% 23.62B
Weighted average by Cap. +0.57%+11.59%+96.86%+140.46%

Financials

2024 2025
Net sales 57.44M 5.9M 5.17M 4.77M 4.46M 8.39M 558M 8.58M 22.17M 275M 22.17M 21.69M 956M 53.11M 5.46M 4.78M 4.41M 4.12M 7.76M 516M 7.93M 20.5M 255M 20.5M 20.05M 884M
Net income -42.45M -4.36M -3.82M -3.53M -3.29M -6.2M -413M -6.34M -16.39M -204M -16.39M -16.03M -707M -12.15M -1.25M -1.09M -1.01M -943K -1.77M -118M -1.82M -4.69M -58.26M -4.69M -4.59M -202M
Net Debt -47.78M -4.91M -4.3M -3.97M -3.71M -6.98M -464M -7.14M -18.45M -229M -18.45M -18.04M -796M -23.34M -2.4M -2.1M -1.94M -1.81M -3.41M -227M -3.49M -9.01M -112M -9.01M -8.81M -389M
Logo AroCell AB
IDL Diagnostics AB (publ), formerly AroCell AB (publ), is a Sweden-based diagnostic Company engaged in the biotechnology and medical diagnostics industry. The Company focuses on research, development, manufacturing, and commercialization of diagnostic and medical technology products. The Company has a broad product portfolio of In Vitro Diagnostics (IVD) tests that deliver clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics AB (publ) develops tests that are clinically useful and economically viable. The Company provides rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, as well as easy to perform.
Employees
25
Date Price Change Volume
26-06-30 SEK 0.4200 -0.47% 18,204
26-06-29 SEK 0.4220 +0.24% 50,462
26-06-26 SEK 0.4210 -1.64% 2,940
26-06-25 SEK 0.4280 -1.15% 17,217
26-06-24 SEK 0.4330 +1.64% 21,886

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDLDX Stock